⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3365101 | 0.83 | — | — | |
| SCHEMBL1158769 | 0.81 | PPARA (0.58) | — | |
| SCHEMBL10930258 | 0.79 | PPARA (0.61) | — | |
| SCHEMBL11221936 | 0.79 | PPARA (0.61) | — | |
| SCHEMBL1156098 | 0.75 | — | — | |
| SCHEMBL9651043 | 0.75 | CA1 (1.00) | — | |
| SCHEMBL242928 | 0.75 | — | — | |
| SCHEMBL2112171 | 0.73 | — | — | |
| SCHEMBL736693 | 0.73 | — | — | |
| SCHEMBL805368 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-3994897-A | Process for the manufacture of carboxylic acids from methyl ketones | BASF AKTIENGESELLSCHAFT (DT) | 1976-11-30 | — | — | US | claimed |
| US-3984406-A | FROM AN ALKALI METAL PHTHALAMATE AND A HYPOHALITE IN A HALOGEN CATALYST | BASF AKTIENGESELLSCHAFT (DT) | 1976-10-05 | — | — | US | claimed |
| EP-4701735-A1 | HETEROCYCLIC DERIVATIVE AS MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITOR | Nested Therapeutics, Inc. (US) | 2026-03-04 | — | — | EP | disclosed |
| US-20250289811-A1 | HETEROCYCLIC DERIVATIVES AS MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS | NESTED THERAPEUTICS, INC. | 2025-09-18 | — | — | US | disclosed |
| WO-2025133610-A1 | INHIBITORY COMPOUNDS | LOQUS23 THERAPEUTICS LIMITED (GB) | 2025-06-26 | — | — | WO | disclosed |
| EP-4574817-A1 | INHIBITORY COMPOUNDS | LoQus23 Therapeutics Limited (GB) | 2025-06-25 | — | — | EP | disclosed |
| EP-4514471-A1 | HETEROCYCLIC DERIVATIVES AS MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS | Nested Therapeutics, Inc. (US) | 2025-03-05 | — | — | EP | disclosed |
| CN-119487021-A | Heterocyclic derivatives as inhibitors of mitogen-activated protein kinase (MEK) | 内斯特治疗公司 | 2025-02-18 | — | — | CN | disclosed |
| WO-2024226579-A9 | HETEROCYCLIC DERIVATIVE AS MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITOR | NESTED THERAPEUTICS, INC. (US) | 2024-12-26 | — | — | WO | disclosed |
| WO-2024226579-A1 | HETEROCYCLIC DERIVATIVE AS MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITOR | NESTED THERAPEUTICS, INC. (US) | 2024-10-31 | — | — | WO | disclosed |
| US-20230381180-A1 | SMALL MOLECULE MODULATORS OF KSR-BOUND MEK | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 2023-11-30 | — | — | US | disclosed |
| EP-0684229-A1 | Sulfamide derivatives | NIHON BAYER AGROCHEM K.K. (JP) | 1995-11-29 | — | — | EP | disclosed |
| US-4327034-A | CHEMICAL INTERMEDIATE PREPARED FROM A SULFAMIC ACID HALIDE AND A HALOGEN COMPOUND | BASF AKTIENGESELLSCHAFT (DE) | 1982-04-27 | — | — | US | disclosed |
| EP-0009054-A1 | N-Pyrazinecarbonyl-N'-substituted-sulfamoyl-guanidine and processes for preparing same | MERCK & CO. INC. (US) | 1980-04-02 | — | — | EP | disclosed |
| US-4115573-A | N-pyrazinecarbonyl-N'-substituted-sulfamoylguanidine and processes for preparing same | MERCK & CO., INC. (US) | 1978-09-19 | — | — | US | disclosed |
| US-4082749-A | FROM CARBOXAMIDES AND ALKALI METAL HYPOCHLORITE, CATALYST | BASF AKTIENGESELLSCHAFT (DT) | 1978-04-04 | — | — | US | disclosed |
| US-3994897-A | Process for the manufacture of carboxylic acids from methyl ketones | BASF AKTIENGESELLSCHAFT (DT) | 1976-11-30 | — | — | US | disclosed |
| US-3992444-A | BY REACTION OF A SULFAMIC ACID WITH AN ACID HALIDE | BASF AKTIENGESELLSCHAFT (DT) | 1976-11-16 | — | — | US | disclosed |
| US-3984406-A | FROM AN ALKALI METAL PHTHALAMATE AND A HYPOHALITE IN A HALOGEN CATALYST | BASF AKTIENGESELLSCHAFT (DT) | 1976-10-05 | — | — | US | disclosed |
| US-3935201-A | Production of 2,1,3-benzothiadiazin-4-one-2,2-dioxides | BASF AKTIENGESELLSCHAFT (DT) | 1976-01-27 | — | — | US | disclosed |